Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
| Autor: | Sanne Patiwael, Christian U. Blank, Ton N. Schumacher, Antoni Ribas, John B. A. G. Haanen, Anastasia Gangaev, Daisy Philips, Dirk Schadendorf, Joost H. van den Berg, Maartje W. Rohaan, Bastian Schilling, Elisa A. Rozeman, Pia Kvistborg, Olga I. Isaeva |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Receptors Antigen T-Cell alpha-beta Programmed Cell Death 1 Receptor Medizin Epitopes T-Lymphocyte CD8-Positive T-Lymphocytes Lymphocyte Activation Epitope Cohort Studies Epitopes melanoma-reactive CD8 T cells Receptors PD-1 80 and over Cytotoxic T cell CTLA-4 Antigen Hepatitis A Virus Cellular Receptor 2 Immune Checkpoint Inhibitors Melanoma Cancer alpha-beta Aged 80 and over Multidisciplinary Middle Aged Biological Sciences medicine.anatomical_structure 5.1 Pharmaceuticals Antigen Female Development of treatments and therapeutic interventions medicine.symptom Melanoma-Specific Antigens Adult Receptors CXCR5 T cell In Vitro Techniques Clinical Research medicine Humans Aged business.industry Compartment (ship) T-Cell medicine.disease CXCR5 Blockade Kinetics T-Lymphocyte Mechanism of action CTLA-4 Cancer research business |
| Zdroj: | Proc Natl Acad Sci U S A Proceedings of the National Academy of Sciences of the United States of America, vol 118, iss 43 |
| ISSN: | 1091-6490 0027-8424 |
| DOI: | 10.1073/pnas.2102849118 |
| Popis: | Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) have revolutionized the treatment of melanoma patients. Based on early studies addressing the mechanism of action, it was assumed that PD-1 blockade mostly influences T cell responses at the tumor site. However, recent work has demonstrated that PD-1 blockade can influence the T cell compartment in peripheral blood. If the activation of circulating, tumor-reactive T cells would form an important mechanism of action of PD-1 blockade, it may be predicted that such blockade would alter either the frequency and/or the breadth of the tumor-reactive CD8 T cell response. To address this question, we analyzed CD8 T cell responses toward 71 melanoma-associated epitopes in peripheral blood of 24 melanoma patients. We show that both the frequency and the breadth of the circulating melanoma-reactive CD8 T cell response was unaltered upon PD-1 blockade. In contrast, a broadening of the circulating melanoma-reactive CD8 T cell response was observed upon CTLA-4 blockade, in concordance with our prior data. Based on these results, we conclude that PD-1 and CTLA-4 blockade have distinct mechanisms of action. In addition, the data provide an argument in favor of the hypothesis that anti-PD-1 therapy may primarily act at the tumor site. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|